Package | us.nlm.vsac |
Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1213.109 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.109/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109 |
Version | 20231215 |
Status | active |
Date | 2023-12-15T19:18:20-05:00 |
Name | OralAnticoagulantIngredientsAndRiskOfGIBleeding |
Title | Oral Anticoagulant Ingredients and Risk of GI Bleeding |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
No narrative content found in resource